JournalLicensing

Royalty stacking: paying two institutions for one product

Royalty stacking explained for Indian licensees: how two public institution royalties add up on one product, a worked rupee example and the clauses that cap it.

By Sahil Sheikh, Regd. Patent & Trademark Agent, cRTTP 8 min read

Part of the guide Licensing technology from Indian institutions: the complete guide for companies

Short answer

Royalty stacking is when one product needs licences from two or more owners and each charges royalty on the full product price. In India, ICMR charges 2% of net sales for licensing, NIT Calicut 1% to 4% depending on TRL, and DRDO 2% on non-government sales. Two such licences on one product can take 3% to 6% of net sales.

A diagnostic device, a food process or a formulation often draws on more than one piece of licensed technology. One part may come from an ICMR institute, another from an NIT or IIT. Each licence comes with its own royalty, and each institution sets that royalty as if its technology were the whole product. Add them up and the licensee can be paying a share of sales that the product's margin never planned for.

That build-up is called royalty stacking. This post shows how it happens with published Indian institutional rates, works through an example in rupees, and sets out the clauses that keep it in check. It is practical guidance from licensing practice, not legal advice.

What is royalty stacking?

Royalty stacking is what happens when a single product carries two or more royalties, each calculated on the same sales. The problem is arithmetic. Two licensors who each ask for 3% of net sales between them take 6%, and neither of them sees the other's invoice.

In India the risk is higher than it looks, for one reason: public institutions often fix their royalty by policy. A company cannot always bargain the second royalty down because it is already paying the first. The room to negotiate sits elsewhere, mainly in the royalty base, which I come to below.

What do Indian public licensors charge?

The rates below come from three published policies. Each applies only to that institution; there is no national royalty rate.

Licensor and source Royalty Base and term Other payments
ICMR, Guidelines for Technology Development Collaboration (2024), section 5.1 2% for licensing; 1% where material is transferred for product development Net sales by the licensee, sublicensees and associates (section 5.2); 10 years from commercialisation (section 5.3) Set in each Expression of Interest and agreement
NIT Calicut, Technology Transfer Policy 2024, section 8(b) 1% at TRL 1 to 3; 1% to 4% between TRL 3 and 7; 4% at TRL 7 or above Net sales, excluding GST, other levies and discounts Upfront fee of at least 25% of development cost above TRL 7, at least 20% below TRL 6; no minimum stated for TRL 6 to 7 (section 8(a))
DRDO, ToT Policy 2025, clause 6.3.1 Nil on sales to defence services and government departments in India; 2% on other sales in India and on exports Net sales value ToT fee as a share of project cost (clauses 6.1 and 6.2)

Two things stand out. First, the rates are modest on their own. Second, they are not designed with each other in mind. ICMR's 2% and NIT Calicut's 4% were each set for a licensee that takes one technology, and nothing in either policy reduces the rate because a second institution is also being paid.

Where a stacked royalty goes: an illustration

5% of net sales
40%60%
ICMR licence2% under section 5.1 of the 2024 guidelines40%
NIT Calicut licence3%, within the 1% to 4% band for TRL 3 to 760%
Invented example. Your rates depend on each agreement.

A worked example in rupees

Illustration with invented figures. A Pune MSME builds a point-of-care diagnostic reader. The sensing chemistry is licensed from an ICMR institute at 2% of net sales. The signal-processing method is licensed from NIT Calicut at 3% of net sales, the TRL 3 to 7 band. Both royalties are written on the full net sales of the reader.

Line Amount
Units sold in the year 2,000
Net selling price per reader, excluding GST ₹15,000
Net sales ₹3,00,00,000
ICMR royalty at 2% ₹6,00,000
NIT Calicut royalty at 3% ₹9,00,000
Total royalty ₹15,00,000
Gross margin at an assumed 30% ₹90,00,000
Royalty as a share of gross margin 16.7%

Five per cent of sales does not sound like much. One sixth of gross margin does. And this reader has only two licensed inputs. A third licence at 2% would push the total to 7% of sales and nearly a quarter of gross margin.

Now suppose the NIT agreement had apportioned the base. The signal-processing method sits in firmware and a circuit board that make up, say, 25% of the reader's cost. If the parties had agreed that the NIT royalty applies to 25% of net sales for this product, the NIT royalty falls to ₹2,25,000 (3% of ₹75,00,000). Total royalty becomes ₹8,25,000, or 2.75% of sales and 9.2% of gross margin. The rate never changed. The base did.

How to keep stacked royalties under control

There are four tools. The first two work best with public institutions, whose rates are often fixed.

Apportion the base for combination products. Agree in writing what share of the product's net sales each licence applies to. A fixed percentage is easier to administer than a cost ratio recalculated every year. The royalty base explainer covers how ICMR and NIT Calicut define net sales; neither policy, as I read it, deals with combination products, so the agreement has to.

Use the policy's own range. NIT Calicut's policy gives a 1% to 4% band between TRL 3 and 7. If your product needs a second licence, say so while the rate is still being set, and show the numbers. A licensor choosing within a band can weigh your total burden. ICMR's 2% is a fixed figure, so there is less room there.

Negotiate an anti-stacking clause. In private deals, and sometimes with universities that have flexible policies, a licensee can ask for this: for every rupee paid to third parties for the same product, the royalty under this licence falls by a set share, often half, down to a floor. Write the floor as a percentage of net sales so the licensor knows its minimum.

Check freedom to operate early. Stacking often starts after launch, when a company discovers a third patent it needs. A freedom-to-operate search before the first licence is signed tells you how many royalties the product will carry, while you can still design around one of them.

Before you sign the first licence

1
Map every inputList each patented or licensed part of the product
2
Run an FTO searchFind third-party patents you will need
3
Model the total royaltyAdd every rate against your gross margin
4
Raise it with each licensorAsk for an apportioned base or a range
5
Write it into each agreementCombination product and anti-stacking terms

What anti-stacking looks like in a clause

A workable clause has four parts. Each one matters, and leaving any out tends to cause the dispute the clause was meant to prevent.

Part What to write Why
Trigger Royalties actually paid to unaffiliated third parties for rights needed to make or sell the same licensed product Stops credit for optional or related-party licences
Offset Royalty under this licence reduced by 50% of those third-party royalties Shares the burden instead of shifting it entirely
Floor Royalty never falls below a stated rate, for example 1.5% of net sales Gives the licensor certainty
Evidence Copy of the third-party agreement's royalty terms or a chartered accountant's certificate Lets the licensor verify the offset

The percentages in that table are examples, not a market standard. I have not found published Indian data on how often anti-stacking clauses are agreed, and I would be cautious of anyone who quotes a "typical" figure.

What if the institutions co-own the technology?

Stacking is mainly a problem of separate owners. When two institutions co-own one patent, the usual approach is a single licence and a single royalty, which the co-owners divide under their own joint ownership agreement. DRDO's ToT Policy 2025, clause 6.3.2(i), says royalty on jointly owned IPR follows the joint ownership agreement. ICMR's 2024 guidelines say ICMR and its own institutes have equal rights on IP (section 14(iv)), and they treat foreground IP from joint development as jointly owned by ICMR and the co-developer (section 9.2).

If you are offered two separate licences from two co-owners of the same patent, ask why. A single agreement signed by both is cleaner, and it removes the risk that each co-owner charges a full rate. Joint patents between universities and industry explains the co-ownership mechanics.

Two licences on one product, with and without terms

Stacked
Each royalty on full net sales
Total set by adding rates
Third licence squeezes margin further
vs
Managed
Base apportioned per licence
Anti-stacking offset with a floor
FTO done before signing

Same rates, very different share of margin.

Common mistakes

  • Signing the first licence before knowing whether a second one is needed.
  • Accepting royalty on full net sales for a technology that is one component of a larger product.
  • Treating a fixed policy rate as the end of the negotiation, when the base is still open.
  • Writing an anti-stacking clause without a floor, so the first licensor rejects it outright.
  • Forgetting upfront fees and minimum royalties. NIT Calicut's policy, for instance, expects an upfront fee alongside royalty and allows an annual minimum (section 8(d)(i)); stacked minimums hurt most in the first slow years. See minimum annual royalty for how floors work.

My view: model the total royalty against gross margin before you approach any licensor, and bring that model to every negotiation. Public institutions respond better to a clear, honest calculation than to a general request for a lower rate. For how individual rates are argued, see how much royalty is fair.

If you are still choosing between technologies, it helps to see early which products would need several licences. Zernyx Hub has mapped patents from universities across India, with AI business insight on each, so you can compare options before the royalties are fixed.

Common questions

What is royalty stacking?

Royalty stacking is the build-up of several royalties on one product, because the product uses technology licensed from more than one owner. Each licensor usually prices its royalty as if it were the only one, so the total can exceed what the product's margin supports.

What is an anti-stacking clause?

An anti-stacking clause lets the licensee reduce one licensor's royalty when it has to pay royalties to third parties for the same product, usually by a set share of those third-party payments, down to an agreed floor. It has to be negotiated; Indian public licensing policies do not provide one by default.

Can I negotiate an ICMR royalty down because I also pay another institution?

The rate is hard to move, because ICMR's 2024 Guidelines for Technology Development Collaboration fix 2% of net sales for licensing. The more realistic route is the royalty base: agree in writing how net sales are apportioned when the licensed technology is only one part of a combination product.

Does royalty stacking apply when two institutions co-own one patent?

Usually less so. Co-owners of one patent normally license together and share one royalty between themselves under their joint ownership agreement. DRDO's ToT Policy 2025, for example, says royalty on jointly owned IPR follows the joint ownership agreement. Stacking is mainly a problem when the technologies, and the owners, are separate.

Sahil Sheikh
About the author

Sahil Sheikh, Regd. Patent & Trademark Agent, cRTTP

Chief IP & Technology Officer, Zernyx Innovations

Connect on LinkedIn

Find a technology you can own.

Search patented technologies from Indian universities and labs, check their readiness and license the right one on Zernyx Hub.

Explore Zernyx Hub

Keep reading

Looking for something else?